EFEvgeny Dmitrievich Fedorov

Evgeny Dmitrievich Fedorov

*This is an algorithmically generated author record based on publicly available information.

Evgeny Dmitrievich Fedorov has a total of 465 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Russian consensus on unresolved issues in the diagnosis and treatment of patients with adenomas of the major duodenal papilla

    by Yu. G. Starkov, A. I. Vagapov, M. Yu. Agapov, K. I. Alekseev, G. V. Belova, A. A. Budzinsky, S. A. Budzinsky, M. I. Bykov, A. S. Vodoleev, D. V. Gusev, et al.

    The Vladivostok Consensus is a consensus document addressing current and unresolved issues in the diagnosis and treatment of patients with adenomas of the major duodenal papilla. It was developed by a group of leading Russian experts in pancreatobiliary endoscopy and endoscopic surgery. The purpose of this Consensus is to systematize, expertly evaluate, and harmonize the positions of Russian specialists on the most controversial aspects of managing this patient population. These include diagnostic issues, selection of optimal treatment strategies, prevention and treatment of intraoperative and postoperative complications, as well as postoperative monitoring and patient care. This document is intended to promote the unification of clinical approaches and improve the effectiveness of diagnosis and treatment of patients with adenomas of the major duodenal papilla.

  • Open Access

    A portal fistula in a patient with large common bile duct stones - the cause of fatal bleeding during endoscopic transpapillary intervention

    by S. A. Budzinskiy, S. G. Shapovalyants, L. M. Mikhaleva, M. A. Anishchenko, A. V. Shulayev, A. S. Melnikova, N. S. Solovjev, K. Yu. Midiber, E. D. Fedorov, С. А. Будзинский, et al.

    The aim: To describe a rare case of a bilioportal fistula in a patient with large multiple common bile duct (CBD) stones complicated by massive intraoperative bleeding. Clinical case: A 40-year-old female patient with clinical and instrumental signs of multiple large CBD stones, moderate mechanical jaundice and signs of anemia of unclear genesis was hospitalized for endoscopic retrograde transpapillary intervention. At the stage of performing endoscopic mechanical lithotripsy, profuse bleeding from the CBD occurred, which did not respond to endoscopic hemostasis. Performed laparotomy, duodeno- and choledochotomy also did not allow to detect the source of bleeding. After preventive stitching of the endoscopic papillotomy area, drainage of the CBD, the patient was transferred to the intensive care unit, where she died due to decompensation of cardiovascular activity. At the autopsy, a bilioportal fistula was found, which was formed as a result of bedsore by a biliary stone of the wall of the CBD and portal vein, which served as a source of massive fatal bleeding. Conclusion: The described complication is casuistic, however, awareness of it, precision collection of anamnesis, timely diagnosis and treatment of gallstone disease can help to avoid a fatal outcome in the future.

  • Open Access

    Biological Therapy for Complicated Forms of Eosinophilic Esophagitis

    by V. O. Kaybysheva, A. S. Balabanov, A. I. Mokritskiy, E. V. Gorbachev, K. S. Maslyonkina, L. M. Mikhaleva, E. D. Fedorov, S. G. Shapovalianc, В. О. Кайбышева, А. С. Балабанов, et al.

    Aim: to evaluate the efficacy and safety of dupilumab, a biologic therapy, in the treatment of refractory eosinophilic esophagitis complicated by esophageal strictures and food impaction, in patients who have failed prior therapy with proton pump inhibitors and topical glucocorticosteroids. Materials and methods. In a prospective study conducted from July 2024 to February 2026, 19 patients (2 females, 17 males) aged 19 to 70 years with a previously confirmed diagnosis of eosinophilic esophagitis were administered dupilumab at a dose of 300 mg once weekly subcutaneously for 12 weeks. Indications for dupilumab administration included a complicated disease course (esophageal strictures and narrowing, esophageal dissection, recurrent episodes of acute food impaction) in the setting of resistance to prior therapy with topical glucocorticosteroids and/or proton pump inhibitors. Additional criteria for initiating biologic therapy included coexisting T2-associated diseases, such as bronchial asthma, chronic rhinosinusitis with nasal polyposis, and atopic dermatitis. All patients underwent assessment of dysphagia severity according to the Dysphagia Symptom Questionnaire (DSQ), calculation of the clinical and morphological disease activity index, esophagogastroduodenoscopy with esophageal biopsy (at least 6 biopsy specimens from the distal and middle/proximal esophagus), and histopathological examination of biopsy specimens both prior to treatment and at 12 weeks of therapy. Results. At 12 weeks of dupilumab therapy, complete resolution of dysphagia was observed in 9 (75 %) of 12 patients with dysphagia at baseline, and clinical remission (absence of any complaints) was achieved in 12 (63.2 %) of 19 patients. The mean DSQ score, reflecting dysphagia severity, decreased from 32.01 to 7.12 (p < 0.05). Endoscopic disease activity, as assessed by the EREхFS score, decreased from 5.0 [4.0; 7.0] to 1.0 [1.0; 3.0] points (p < 0.0001). Although the proportion of patients with strictures did not change significantly, an increase in esophageal diameter at the stricture site was observed (from 13.1 ± 5.8 mm to 16.1 ± 2.0 mm; p < 0.05). Histological remission (< 15 eosinophils per HPF, ×400) was achieved in 18 (94.7 %) of 19 patients. Adverse events included upper extremity joint pain (1 patient, 5.3 %), conjunctival dryness (2 patients, 10.5 %), and peripheral blood eosinophilia with elevated liver enzymes up to 3–4 times the upper limit of normal (1 patient, 5.3 %). Conclusions. Dupilumab therapy over 12 weeks leads to the achievement of clinical (63.2 %) and histological (94.7 %) remission in eosinophilic esophagitis.

  • Open Access

    Clinical Case of Radical Transpapillary Endoscopic Treatment of a Patient with Type IV Mirizzi Syndrome

    by S. A. Budzinskiy, M. V. Murashkina, S. G. Shapovalyants, A. S. Melnikova, A. V. Shulaev, E. N. Platonova, E. D. Fedorov, С. А. Будзинский, М. В. Мурашкина, С. Г. Шаповальянц, et al.

    Aim: to demonstrate the feasibility of intraductal contact lithotripsy using a holmium laser under peroral transpapillary cholangioscopy (POCS) guidance for radical endoscopic treatment of a patient with type IV Mirizzi syndrome. Key points. A 58-year-old female patient with a 5-year history of cholelithiasis was admitted on an emergency basis one year earlier with clinical signs of obstructive jaundice. At that time, endoscopic intervention was performed, including endoscopic retrograde cholangiopancreatography (ERCP), endoscopic sphincterotomy, and biliary duodenal stenting. ERCP revealed a 4.0 × 2.0-cm calculus completely obstructing the common bile duct lumen, and a cholecystobiliary fistula was suspected. During the current hospitalization, the first stage of treatment consisted of balloon dilation of the previously performed endoscopic sphincterotomy followed by POCS using the SpyGlass DS II system. Complete obstruction of the common bile duct lumen by the calculus was confirmed, together with pronounced inflammatory changes in the bile duct wall at the site of the cholecystobiliary fistula. Contact lithotripsy of the biliary calculus was performed using a holmium laser, with fragmentation of both the intraductal and gallbladder portions of the calculus, followed by extraction of the fragments and placement of a nasobiliary drain. At the second stage, complete clearance of the main bile ducts and the gallbladder cavity was achieved under POCS guidance. A procedural complication — impaction and breakage of the extraction basket in the distal common bile duct — was also successfully managed by contact holmium laser lithotripsy performed through the basket mesh, followed by basket removal after fragmentation of the impacted biliary stone. Repeat stenting and cholecystectomy were not performed due to a shrunken gallbladder and complete clearance of the biliary tract, including the gallbladder. Conclusion. The endoscopic approach enabled radical treatment and obviated the need for surgery, demonstrating its potential in the management of complex forms of choledocholithiasis, including Mirizzi syndrome.

  • Fibrostenotic complications of eosinophilic esophagitis

    by A.I. Mokritsky, V.O. Kaybysheva, E.D. Fedorov, S.G. Shapovalianc

    Objective. To present clinical case description of complicated eosinophilic esophagitis, including an analysis of disease course features, diagnostic criteria, and approaches to pharmacological and surgical management. Case report. Case of young male (born in 1997) suffering from dysphagia with regular episodes of food impaction in the esophagus are described. Multiple endoscopic studies in the patient medical history did not reveal obvious causes for the episodes of acute obstructive dysphagia; however, in neither case were esophageal biopsies performed or adequate pharmacological therapy initiated. The outcome of a prolonged (7—10 years) active immune-inflammatory process in the esophagus was the development of severe fibrostenotic changes in the esophageal wall, such as rings and strictures with a diameter less than 5 mm. These complications led to severe dysphagia, weight loss, and a marked decrease in quality of life. Pharmacological therapy and balloon dilation of the esophageal strictures helped reduce symptom severity. However, the developed fibrostenotic complications resulted in irreversible remodeling of the esophageal wall in this young man. Conclusion. The presented case underscore the importance of timely disease diagnosis and the initiation of pharmacological therapy to prevent the progression of inflammatory processes and the development of irreversible fibrosclerotic changes in the esophageal wall. In cases where strictures and dysphagia have already developed and do not resolve with pharmacological therapy, patients with eosinophilic esophagitis require endoscopic intervention (balloon dilation or bougienage of the esophagus) to resolve dysphagia and normalize their quality of life.

  • Endoluminal endoscopic surgery in the treatment of patients with early cardioesophageal junction cancer: a comparative analysis with surgical treatment

    by S.A. Sokolov, S.S. Pirogov, A.B. Ryabov, E.D. Fedorov, M.V. Moscalec, A.O. Shveikin, N.M. Abdulkhakimov, D.YU. Kanner

    Objective. To compare the immediate outcomes, long-term oncological outcomes, and quality of life after endoscopic submucosal dissection and surgery in patients with early cardioesophageal cancer (cTis–cT1N0M0, Siewert type II), and to evaluate the possibility of expanding indications for dissection in comorbid patients. Material and methods. A non-randomized multicenter study included 98 patients (endoscopic treatment — 74, surgery — 24). Due to the low radicality of mucosal resection, only the endoscopic submucosal dissection subgroup (n=55) was compared with surgery. After pseudorandomization, two groups of 24 patients each were formed. We analyzed 5-year overall survival, local control, progression-free survival, complications, hospital stay, and quality of life. Results. Endoscopic submucosal dissection compared with surgery (after pseudorandomization, n=24 each): overall survival 87.5% and 90.5% (p=0.7); local control 95.8% and 94.4% (p=0.98); progression-free survival 95.8% and 90.5% (p=0.58); hospital stay 7 and 11 days (p=0.0002); quality of life (total score of the questionnaire, higher — worse) 0.9 and 7 points (p=0.00002). After surgery, quality of life deteriorated (p=0.02), whereas after dissection it did not change (p=0.371). In 13 comorbid patients (Charlson 7—8, ASA III), dissection was performed according to indications expanded relative to standard criteria (comparison with the standard indication group, n=40): tumor size 20 vs 15 mm, p=0.03; cT1b invasion 92.3% vs 17.5%, p=0.00026; poorly differentiated adenocarcinoma 30.8% vs 5%, p=0.016, respectively. Five-year results (expanded indications vs standard): local control 92.3% vs 97.3% (p=0.36), overall survival 59.1% vs 81.2% (p=0.62), progression-free survival 79.4% vs 97.3% (p=0.008), respectively. Conclusion. Endoscopic submucosal dissection for early cardioesophageal junction cancer is non-inferior to surgery in terms of overall survival, local control, and progression-free survival, while providing a shorter hospital stay and better quality of life. Expanding indications is possible in comorbid patients but requires strict dynamic monitoring.

  • Open Access

    Current Clinical Guidelines for the Management of Patients with Eosinophilic Esophagitis

    by Oksana M. Drapkina, Vladimir T. Ivashkin, Igor V. Maev, Leyla S. Namazova-Baranova, Aleksandr A. Baranov, Musa R. Khaitov, Lyudmila M. Mikhaleva, Valeria O. Kaybysheva, Elena A. Vishneva, Evgeniy D. Fedorov, et al.

    This article presents an analysis of current clinical guidelines for the management of patients with eosinophilic esophagitis (EoE) — a chronic immune-mediated disease of the esophagus characterized by eosinophilic infiltration of the mucosa (≥ 15 eos/hpf) and clinical manifestations of esophageal dysfunction. The review highlights key changes in diagnostic approaches and discusses contemporary treatment strategies, including dietary therapy (starting with the least restrictive diets), pharmacological treatment (proton pump inhibitors, topical steroids, biologic therapy), and endoscopic dilation for strictures. The authors emphasize the need for comprehensive monitoring (clinical, endoscopic, and histological) to assess treatment response and for long-term maintenance therapy given the chronic nature of the disease. Special attention is paid to pediatric aspects of patient management.


  • Clinical and morphological characteristics of eosinophilic esophagitis with surgical complications

    by V. O. Kaybysheva, E. V. Gorbachev, A. I. Mokritsky, E. D. Fedorov, S. G. Shapovalyants

    Objective. To study the clinical, laboratory, endoscopic, and pathomorphological features of eosinophilic esophagitis with surgical complications. Material and methods. 113 patients with a confirmed eosinophilic esophagitis (based on esophagogastroduodenoscopy with esophageal biopsy) underwent a comprehensive examination including assessment of complaints, medical history, comorbidities, and nutritional status. Laboratory blood tests, esophagogastroduodenoscopy with endocytoscopy and esophageal biopsy, and pathomorphological examination of biopsy specimens were performed. Some patients also underwent barium esophagogram. Results. Complications leading to endoscopic and/or surgical interventions were recorded in 27.4% of patients with eosinophilic esophagitis. Complicated forms of eosinophilic esophagitis were characterized by more severe clinical manifestations (dysphagia and food impaction were observed in 96.7% of patients), changes in laboratory tests (blood eosinophilia and elevated IgE level), a high score on the EREхFS scale (more than 6 points), detection of strictures during endoscopic examination, and fibrosis in the subepithelial layer upon histopathological examination. Conclusion. One-third of eosinophilic esophagitis cases are complicated, requiring patients to seek urgent endoscopic and surgical care. Most patients with a complicated course are young men under 30 years of age, suffering from persistent dysphagia and recurrent food impaction episodes. Esophagogastroduodenoscopy in patients with eosinophilic esophagitis reveals characteristic signs of mucosal inflammation – edema, exudate, and longitudinal furrows; in cases of delayed diagnosis, rings and strictures are found in the esophagus. To prevent complications, every patient with unexplained dysphagia (especially with episodes of food impaction) should undergo endoscopic examination of the esophagus with multiple biopsies for timely diagnosis and initiation of anti-inflammatory therapy.

  • Russian consensus on the diagnosis and treatment of gastroduodenal ulcerative bleeding

    by A.V. Shabunin, P.A. Yartsev, Z.A. Bagatelia, D.N. Grekov, P.A. Drozdov, A.A. Karpov, A.V. Klimashevich, I.YU. Korzheva, S.S. Lebedev, E.P. Rodionov, et al.

    The Russian consensus document on current issues in diagnosis and treatment of gastroduodenal ulcerative bleeding was prepared by a group of experts in surgery, endoscopy, interventional radiology and intensive care. The purpose of this consensus was to identify and consolidate opinions of Russian specialists on such current issues as diagnostic measures for gastroduodenal ulcerative bleeding, timing of diagnosis and order of diagnostic tests, as well as necessity and feasibility of conservative measures for gastroduodenal ulcerative bleeding, analysis of surgical strategy depending on severity of bleeding.

  • Efficacy of Elimination Diets in the Treatment of Adult Patients with Eosinophilic Esophagitis

    by V. O. Kaybysheva, S. V. Tikhonov, E. D. Fedorov, S. G. Shapovalianc

    Aim : to assess the efficacy of dietary treatment regimens in eosinophilic esophagitis patients. Materials and methods. Twenty-seven patients (1 woman and 26 men) aged 24 to 61 years with a previously confirmed diagnosis of eosinophilic esophagitis (according to esophagogastroduodenoscopy with esophageal biopsy: > 15 eosinophils per high-power field, ×400) off therapy were instructed on dietary exclusions as the only treatment method. Three patients were placed on a targeted diet based on allergy testing; 17 patients followed a two-food elimination diet; and 7 patients followed a six-food elimination diet. All patients underwent esophagogastroduodenoscopy with esophageal biopsy (6 specimens from the distal and middle/proximal portions) and histopathological examination of biopsy specimens, as well as questionnaire-based assessment of dysphagia severity before and after 12 weeks of dietary therapy. Results . After 12 weeks of dietary therapy, histological remission was achieved in 3 of 7 (42.9 %) patients who followed the six-food elimination diet, in 7 of 17 (41.2 %) patients who followed two-food elimination diet, and in 1 of 3 (33.3 %) patients on a target diet (differences were not statistically significant). Complete resolution of dysphagia was ob served in 1 (33.3 %) patient who followed a target diet, in 8 of 14 (57.1 %) patients with dysphagia in the two-food elimination diet group, and in 3 of 5 (60 %) patients with dysphagia on the six-food elimination diet (differences were not statistically significant). Conclusions . The efficacy of two-food and six-food elimination diets is comparable and allows histological remis sion to be achieved in 41.2–42.9 % of patients with eosinophilic esophagitis.